Tuesday, October 23, 2007

Life Links 10/23/07

On October 27 at 9 p.m. ET, Fox News will air a program dealing with abortion choices.
In the scene FOX does not focus on the surgical details of the abortion procedure, but it is emotionally wrenching, however, as the woman cries through the abortion and her mother, beside her for emotional support, learns this is her daughter's second abortion in less than a year.

The FOX documentary profiles three women to explore the abortion issue by following their agonizing decisions to have their babies or terminate their pregnancies.

The Cape Cod Times is the first mainstream media outlet to report on the death of Laura Smith. Smith died after undergoing an abortion in September.
Eileen Smith wants more information about what led to her daughter's death. She is now represented by a Boston lawyer who filed a complaint for discovery Oct. 4 in Barnstable Superior Court to obtain medical records and autopsy results.

Named in the court complaint are Cape Cod Hospital, the state medical examiner's office, Cape & Island Center for Women's Health at 68 Camp St., and gynecologist Rapin Osathanondh, a state-licensed physician with offices at 68 Camp St. and in Brookline.

Osathanondh did not respond to two phone messages left on his cell phone requesting an interview. His attorney also did not return a call requesting an interview. A Times reporter also went to the women's health clinic, but Osathanondh was not available.....

Eileen Smith thought her daughter was strongly opposed to abortion.

"That's the confusion we have," she said. "That is one of the answers I don't have."

A report out of Rutgers is claiming New Jersey will reap "$2.2 billion in economic benefits" by spending $450 million for embryonic stem cell research. This numbers seem really high considering the same kind of prediction out of California claimed they'd make between $6 and $12 billion after spending $3 billion and that estimate has its share of critics.

The Rutgers report estimates the $450 million will result in ".613 therapies" based on the idea that it typically costs $500 million (in 2004 dollars) to develop a new drug. To me that sounds like an extreme case of comparing apples and oranges. The report also notes that the funding creating "one effective therapy directly and completely from the research support it provides" would be "a most favorable case." The caveat section at the end of the paper is also interesting.

Father Thomas Berg on hybrid human-animal cloning debate in Great Britain.

Here's an article in Nature discussing the problems with defining pluripotency and how researchers test to see if cell lines are pluripotent.

No comments:

Post a Comment